| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 222.48B | 259.37B | 249.80B | 274.27B | 244.54B |
| Gross Profit | 107.11B | 116.57B | 99.03B | 114.63B | 106.34B |
| EBITDA | 45.82B | 17.15B | -9.44B | 35.45B | 40.38B |
| Net Income | 26.72B | 20.93M | -25.08B | 18.91B | 23.89B |
Balance Sheet | |||||
| Total Assets | 279.23B | 298.01B | 309.89B | 348.07B | 306.94B |
| Cash, Cash Equivalents and Short-Term Investments | 56.64B | 56.50B | 44.74B | 46.19B | 66.85B |
| Total Debt | 46.04B | 45.59B | 54.28B | 41.43B | 41.05B |
| Total Liabilities | 168.96B | 204.91B | 212.56B | 217.30B | 200.05B |
| Stockholders Equity | 109.54B | 94.40B | 98.59B | 132.25B | 108.57B |
Cash Flow | |||||
| Free Cash Flow | 28.50B | 45.96B | 3.68B | 26.65B | 37.26B |
| Operating Cash Flow | 30.98B | 48.40B | 6.81B | 31.17B | 41.12B |
| Investing Cash Flow | -10.75B | -16.69B | -8.26B | -34.74B | -20.93B |
| Financing Cash Flow | -13.37B | -24.97B | 955.17M | -16.09B | -9.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $47.83B | 35.83 | 120.56% | 0.49% | 36.77% | 102.83% | |
75 Outperform | $71.89B | 29.58 | 103.24% | 1.18% | 6.17% | 35.41% | |
74 Outperform | $306.47B | 23.23 | 23.64% | 2.09% | 8.91% | 14.53% | |
70 Outperform | $37.46B | 11.10 | 29.57% | 2.51% | 1.04% | ― | |
66 Neutral | $31.59B | 17.34 | -0.64% | 2.17% | 14.17% | -102.25% | |
63 Neutral | $43.86B | 49.36 | 4.38% | 2.26% | 5.05% | 115.92% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |